17-ketosteroids and Chronic-Disease

Topics: 17-Ketosteroids; Air Pollution; Carbon Disulfide; Chronic Disease; Fibrinolysis; Humans; Kidney Diseases; Lipid Metabolism; Liver Diseases; Nervous System Diseases; Vascular Diseases

DHEA-S (dehydroepiandrosterone sulfate) has many roles in human body as comprehensive vital power, whose metabolite is urine 17-KS-S (abbreviated S), having function of anti-cortisol. The metabolite of cortisol is urine 17-OHCS (abbreviated OH). DHEA-S is produced not only in adrenal glands but in brain. In order to examine the effects of logotherapy, urine S and OH were examined. Subjects were chronic low back pain patients treated by loxoprofen sodium (NSAID). In Group 1 (n = 11) logotherapy was not added, but in Group 2 (n = 10) it was added. Before the treatment, both groups showed low S and high OH. After 3 weeks, Group 2 showed higher S and lower OH than Group 1. After 18 weeks, 4 cases (40%) were relapsed in Group 2, and 10 (90.9%) were in Group 1 (p < 0.05). Group 2 was divided into 2 groups; relapsed group (n = 4) and non-relapsed group (n = 6). S, OH, S/OH were examined between 2 groups of Group 2 and Group 1. Relapsed group of Group 2 and Group 1 showed lower S and higher OH than non-relapsed group of Group 2. [Discussion] Logotherapy is a method to activate comprehensive human vital power. This is the mechanism through stimulating and activating human brain function.

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Brain; Chronic Disease; Dehydroepiandrosterone Sulfate; Female; Humans; Low Back Pain; Male; Middle Aged; Phenylpropionates; Stimulation, Chemical; Stress, Physiological

Several class I antiarrhythmic drugs were used in an intraindividual comparative study in 15 patients with chronic stable ventricular extrasystole of various origins. In a randomised sequence lidocaine, ajmalin and, in a cross-over double blind study with placebo, the new antiarrhythmic Org 6001 were tested. Propafenon was given as a final preparation. Each substance was administered parentally in therapeutic doses. A significant placebo effect could be excluded, baseline control values before administration of individual substances correlated well. Comparing mean values obtained over one hour before and after administration of the substance it was shown that the effectiveness of drugs decreased as follows: ajmalin, propafenon, lidocaine, Org 6001. Whereas suppression of extrasystole was most marked after ajmalin, propafenon showed the longest period of activity. After Org 6001 divergent activity of arrhythmia could be observed; in some patients good antiarrhythmic effects could be demonstrated. For evaluation of effectiveness and validity of new antiarrhythmic substances intraindividual comparison with placebo and well established standard antiarrhythmic drugs is advisable.

Topics: 17-Ketosteroids; Adult; Aged; Ajmaline; Androstanols; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Chronic Disease; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Placebos; Propiophenones

Topics: 17-Ketosteroids; Androsterone; Cholesterol; Chronic Disease; Clinical Trials as Topic; Computers; Creatinine; Endocrine Glands; Follow-Up Studies; Humans; Male; Methods; Monoamine Oxidase Inhibitors; Phenothiazines; Placebos; Psychiatric Status Rating Scales; Reserpine; Schizophrenia; Semen; Statistics as Topic; Thyroid Gland

We devised a clinical test of renal metabolism based on the synthesis of guanidinoacetic acid from citrulline in the proximal convoluted tubule. Intravenous administration of a citrulline/creatine solution to rats with modified levels of renal glycine amidinotransferase activity revealed a strong correlation (r = 0.921) between this activity and urinary guanidinoacetic acid excretion. Citrulline (1.75 g) and creatine (1.50 g) were administered orally to healthy individuals and patients with chronic glomerulonephritis. In the healthy individuals, urinary guanidinoacetic acid excretion increased 5-fold by 2 h after dosing (15.1 +/- 2.2 vs. 2.8 +/- 1.1 mg/h). In the glomerulonephritis patients, blood clearance of citrulline decreased as the creatinine clearance decreased and urinary guanidinoacetic acid excretion also decreased. Of 56 patients with glomerulonephritis or diabetes mellitus, one had increased urinary guanidinoacetic acid excretion associated with an excess of adrenal androgens. This test appears a useful, noninvasive and simple method for examining the metabolic activity of the renal proximal convoluted tubules.

Topics: 17-Ketosteroids; Amidinotransferases; Animals; Chronic Disease; Citrulline; Creatine; Diabetes Mellitus, Type 2; Female; Glomerulonephritis; Glycine; Humans; Kidney; Kidney Tubules, Proximal; Middle Aged; Ovariectomy; Rats; Rats, Inbred WKY

The content of GABA was measured in blood plasma of 111 patients suffering from Itsenko-Cushing disease. In untreated females, the blood GABA content was noticeably lowered; during treatment it increased, reaching normal, on the average, in patients with a history of total adrenalectomy. The changes in the blood GABA content in male patients were marked to a less degree. In the persons with a history of total adrenalectomy the GABA content turned out higher than normal. The blood GABA content in patients was dependent on the age and disease standing. In males experiencing disease exacerbation, it was appreciably reduced. As compared to females, the degree of a negative correlation between the blood content of GABA and ACTH (or cortisol) in males was more pronounced. The correlation between the excretion of 17-HCS with urine and GABA blood content in men and women was reverse. Women manifested a positive correlation between the excretion of 17-HCS with urine and blood GABA content, whereas men between arterial pressure and blood GABA. The problem of potential disorders of the GABAergic brain system in patients afflicted with Itsenko-Cushing disease is under discussion.

Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Chromatography, Ion Exchange; Chronic Disease; Combined Modality Therapy; Cushing Syndrome; Female; gamma-Aminobutyric Acid; Humans; Hydrocortisone; Male; Middle Aged

Topics: 17-Ketosteroids; Acne Vulgaris; Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Dibenzocycloheptenes; Female; Gas Chromatography-Mass Spectrometry; Humans; Mass Spectrometry; Middle Aged

Sexual function was studied in 76 patients with chronic bronchitis and in 17 healthy males. The study showed a decrease in sexual function of primary hypogonadism type which was in direct relation to the gravity of disease.

Topics: 17-Ketosteroids; Adult; Androsterone; Bronchitis; Chronic Disease; Etiocholanolone; Follicle Stimulating Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Pituitary Gland, Anterior; Testis; Testosterone

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis; Humans; Iontophoresis; Liver Cirrhosis; Male

Topics: 17-Ketosteroids; Adolescent; Adult; Chronic Disease; Follow-Up Studies; Gonorrhea; Humans; Male; Prostate; Prostatitis; Sperm Count; Sperm Motility

Concentrations of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in serum and 17-ketosteroids (17-KS) in urine of 10 paraplegic and 10 quadriplegic subjects were measured from onset of injury and followed once a week for 4 months. Compared with age-matched normal controls, paraplegic subjects showed significantly lower serum levels of LH and FSH for 2 weeks and of testosterone for 6 weeks after spinal cord trauma, following which periods of time these hormones attained normal levels. By contrast, in quadriplegic subjects, serum testosterone concentrations remained significantly lower than those of the controls during the entire 4-month testing period. Furthermore, in another group of 10 chronic (1 to 6 years after onset of injury) paraplegic and 10 chronic quadriplegic subjects, serum testosterone and FSH concentrations were comparable to those of the normal controls. Serum LH concentrations were at control levels in chronic paraplegic but significantly depressed in chronic quadriplegic subjects. The concentrations of urinary 17-KS exhibited sharp fluctuations over the 4-month period and were below control levels in paraplegic but within control limits in quadriplegic subjects. The results indicate that the function of the hypothalamic-pituitary-gonadal axis is disturbed for at least 4 months in quadriplegic subjects.

Topics: 17-Ketosteroids; Adult; Chronic Disease; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Paraplegia; Quadriplegia; Spinal Cord Injuries; Testosterone

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aldosterone; Chronic Disease; Cosyntropin; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Time Factors; Zinc

The occurrence of a giant myelolipoma of the adrenal gland reported in a patient with congenital adrenal hyperplasia (21-hydroxylase deficiency). Associated significant findings include a massive proliferation of adrenocortical cells as an integral part of the myelolipoma and coincidental tumor of the interstitial cells of the testis. The clinical, radiologic, endocrinologic, and pathologic features of this case are correlated with a review of the literature. The additional myelolipomas are also reported here for the first time. Similar lesions have been induced experimentally in rats and provide further evidence suggesting a hyperplastic rather than a neoplastic nature for this complex lesion, at least in its earlier stages.

Topics: 17-Ketosteroids; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Age Factors; Chronic Disease; Diagnosis, Differential; Female; Humans; Male; Microscopy, Electron; Middle Aged; Primary Myelofibrosis; Testicular Neoplasms

Topics: 11-Hydroxycorticosteroids; 17-Ketosteroids; Adnexal Diseases; Adult; Antitubercular Agents; Chronic Disease; Female; Humans; Middle Aged; Time Factors; Tuberculosis, Female Genital; Uterine Diseases

Topics: 17-Ketosteroids; Adult; Androgens; Chronic Disease; Duodenal Ulcer; Humans; Male; Middle Aged; Remission, Spontaneous; Testosterone

Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Chronic Disease; Humans; Liver Diseases; Middle Aged; Remission, Spontaneous

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acute Disease; Adult; Anxiety Disorders; Chronic Disease; Humans; Male; Schizophrenia

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex; Aged; Cholecystitis; Cholelithiasis; Chronic Disease; Humans; Middle Aged

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Amenorrhea; Chronic Disease; Female; Gonadotropins, Pituitary; Humans; Infertility, Female; Menstruation Disturbances; Prolactin

The adrenal cortex functional activity in males with alcoholsim of the 2nd stage (128 cases) in respect to the production of glucocorticoids and mineral-corticoids is decreased. The biosynthesis of androgens, as can be seen by the 17-KS urine excretion, is increased. Abstinence from alcohol during treatment with teturam in combination with neuroleptical drugs was accompanied by an increased elimination of glucocorticoids and a normalization of the metabolic indices of the main electrolytes. In all the examined cases of alcoholism with the 2nd stage irrespective of the duration of the disease there was an increased amount of androgens, possibly as a compensatory reaction to metabolic disturbances, due to chronic alcoholic intoxication.

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Alcoholism; Chronic Disease; Humans; Male; Middle Aged; Pituitary-Adrenal System; Potassium; Sodium

15 adult chronic asthmatic patients who were on daily maintenance dose of oral steroid for at least 6 months were studied. Following an investigation period of 2 weeks, the patients were started on BDA, 100 microgram four times daily. The daily oral steroid dose, which averaged 12 mg of prednisone or its equivalent, was gradually reduced by about 1 mg per day. The trial lasted 8 weeks, at the end of which, ten patients were as good or better on BDA than on oral steroids. Two patients had to return to oral corticosteroid therapy before the trial ended and three patients were unable to discontinue their oral steroid treatment. The lack of systemic effects of BDA was demonstrated by the appearance of symptoms which were apparently previously suppressed by the oral steroids and the excretion of normal amounts of 17-OHCS in the urine in some to the patients who had evidence of adrenal suppression while on oral steroids.

Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aerosols; Asthma; Beclomethasone; Chronic Disease; Humans; Respiratory Function Tests; Substance-Related Disorders

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adult; Aged; Androgens; Cholesterol; Chronic Disease; Female; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Pneumonia; Sialic Acids

Topics: 17-Ketosteroids; Adult; Chronic Disease; Humans; Male; Middle Aged; Prostatitis; Testis; Testosterone

Topics: 17-Ketosteroids; Adolescent; Adult; Aged; Antacids; Benzocaine; Bulgaria; Catecholamines; Chronic Disease; Dehydroepiandrosterone; Drug Combinations; Duodenal Ulcer; Female; Free Radicals; Humans; Male; Middle Aged; Peptic Ulcer; Stomach Ulcer

The neuroendocrine effects of haloperidol therapy have been examined in 62 male chronic schizophrenic patients, aged 16-62 years. The duration of the disease varied between 2 and 29 years. The patients were divided into 48 hebephrenics with onset of the disease at puberty, or immediately after puberty, and 14 paranoids with onset of the disease in adulthood. They received 6 mg i.m.p.d. of haloperidol, for 30 days, up to a total dose of 180 mg. The following hormonal variables were examined before therapy and at 10-20 and 30 days of treatment: total urinary gonadotropins, serum FSH and LH, GH response to insulin stimulation, ACTH reserve (Metyrapone test), total urinary 17-ketosteroids and 17-hydroxycorticoids before and after an ACTH stimulation test, serum testosterone, insulin response to glucose load, plasma thyroxine before and after a TSH stimulation test. The basic hormonal values revealed decreased secretion of total gonadotropins, FSH, LH, ACTH and testosterone, and increased insulin secretion. The haloperidol therapy seemed to stimulate the secretion of FSH, LH, total gonadotropins, ACTH and testosterone, up to normal or low-normal levels. No modifications were observed in the other hormonal variables. The significance of these results is discussed.

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Blood Glucose; Chronic Disease; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Growth Hormone; Haloperidol; Humans; Insulin; Luteinizing Hormone; Male; Middle Aged; Pituitary-Adrenal System; Schizophrenia; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Testosterone; Thyroid Hormones

Impairment of cortisol metabolism, evidence of endogenous hypercortism and sensitivity to oral corticosteroids are known to occur in patients with chronic liver disease. Measurements were made of plasma 11-OHCS and urinary cortisol levels and other parameters of adrenal function in a group of such patients. The mean plasma total 11-OHCS was lower in patients than in control subjects, although this difference was not statistically significant and the normal circadian rhythm was maintained. However, in patients with chronic liver disease a greater proportion of the 11-OHCS was in the non-protein bound state resulting in an elevation of this fraction. This elevation of non-protein bound 11-OHCS must represent a resetting of the pituitary-adrenal feedback mechanism in these patients. Corticosteroid binding globulin was lower in patients than in control subjects, although the difference was not statistically significant. Urinary cortisol excretion was significantly reduced as was excretion of 17-ketosteroids. Cortisol secretion rate was found to be normal. It is suggested that elevation of plasma non-protein bound 11-OHCS, resulting from impaired metabolism and reduced protein binding of cortisol in patients with hepatic disease, may explain the features of endogenous hypercorticism seen in such patients. Moreover, in the presence of impaired steroid metabolism and reduced protein binding, these patients may exhibit an increased sensitivity to corticosteroid therapy, and therefore administration of a reduced dosage may be advisable.

Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Aged; Chronic Disease; Circadian Rhythm; Female; Hepatitis; Humans; Hydrocortisone; Liver Cirrhosis; Male; Middle Aged; Protein Binding; Transcortin

On the basis of own investigations of the testosteron metabolism in hepatopathy must be assumed that the hypogonadism appearing in liver diseases is to be regarded as peripheral form, i.e. it is not centrally evoked by gonadotropin insufficiency. An own pathogenetic concept is discussed.

Topics: 17-Ketosteroids; Age Factors; Chronic Disease; Estrogens; Humans; Hypogonadism; Liver Diseases; Male; Testosterone

Topics: 17-Ketosteroids; Adult; Chronic Disease; Estrogens; Female; Humans; Male; Middle Aged; Pregnanediol; Prostatitis; Sexual Dysfunction, Physiological

Topics: 17-Ketosteroids; Adult; Aged; Chronic Disease; Female; Hepatitis; Humans; Hydroxycorticosteroids; Hydroxysteroids; Hypersplenism; Ketosteroids; Liver Cirrhosis; Male; Middle Aged; Splenomegaly

Topics: 17-Ketosteroids; Adult; Age Factors; Aged; Chronic Disease; Cystitis; Estrogens; Female; Gonadal Steroid Hormones; Humans; Male; Menopause; Middle Aged; Sex Factors; Testosterone; Urinary Bladder Neoplasms

Topics: 17-Ketosteroids; Adolescent; Adult; Age Factors; Androgens; Androstanes; Androsterone; Chronic Disease; Dehydroepiandrosterone; Etiocholanolone; Homosexuality; Hospitalization; Humans; Male; Schizophrenia; Testosterone

Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Air Pollution; alpha 1-Antitrypsin; Asthma; Bronchitis; Chronic Disease; Coal Mining; Cystic Fibrosis; Diagnosis, Differential; Humans; Lung Diseases, Obstructive; Occupational Diseases; Pulmonary Emphysema; Respiratory Hypersensitivity; Respiratory Tract Infections; Rural Population; Smoking; Socioeconomic Factors; Urban Population

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adult; Aged; Chronic Disease; Female; Humans; Male; Middle Aged; Pancreatitis

Topics: 1-Propanol; 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Age Factors; Aged; Antineoplastic Agents; Chronic Disease; Female; Humans; Lymphatic Diseases; Male; Middle Aged; Piperazines; Pituitary-Adrenal Function Tests; Sex Factors; Spiro Compounds

Topics: 17-Ketosteroids; Adolescent; Adult; Child; Chronic Disease; Cushing Syndrome; Estrogens; Female; Humans

Topics: 17-Ketosteroids; Adult; Androsterone; Chronic Disease; Cysts; Dehydroepiandrosterone; Estrogens; Etiocholanolone; Female; Heme; Hemeproteins; Humans; Levulinic Acids; Mastitis; Menstruation; Middle Aged; Ovulation; Porphobilinogen; Porphyrins; Pregnancy; Pregnanes; Pregnanetriol; Vitamin E

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Alopecia Areata; Chronic Disease; Circadian Rhythm; Female; Humans; Male; Pituitary-Adrenal Function Tests

Topics: 17-Ketosteroids; Adult; Alcohol Drinking; Alcoholism; Chronic Disease; Disulfiram; Humans; Insulin; Male; Middle Aged; Sex Factors; Substance Withdrawal Syndrome

Topics: 17-Ketosteroids; Aged; Aging; Blood Protein Electrophoresis; Blood Viscosity; Calcium; Cholesterol; Chronic Disease; Humans; Intracranial Arteriosclerosis; Lipoproteins; Male; Mental Disorders; Middle Aged; Osteoporosis; Stress, Psychological

Topics: 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Androstanes; Arthritis; Arthritis, Rheumatoid; Chronic Disease; Circadian Rhythm; Dehydroepiandrosterone; Delayed-Action Preparations; Female; Glucocorticoids; Humans; Hydrocortisone; Hypothalamus; Insulin; Male; Middle Aged; Pituitary Gland; Prednisolone; Psoriasis

Topics: 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Angiography; Blood Pressure Determination; Chronic Disease; Creatinine; Female; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Nephrosclerosis; Pituitary-Adrenal Function Tests

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Alcohol Oxidoreductases; Alcoholism; Aldehyde-Lyases; Chronic Disease; Enzymes; Estrogens; Gonadotropins; Hepatitis; Histocytochemistry; Humans; Italy; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Ornithine Carbamoyltransferase; Porphyrias; Porphyrins; Pregnanediol; Transaminases

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acute Disease; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Chromatography, Thin Layer; Chronic Disease; Coronary Disease; Glucocorticoids; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Time Factors

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adult; Chronic Disease; Female; Gestational Age; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Rheumatic Fever

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Glands; Adult; Chelating Agents; Chronic Disease; Environmental Exposure; Female; Humans; Liver; Male; Mercury Poisoning; Middle Aged; Occupational Diseases; Sulfhydryl Compounds

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Atrophy; Chronic Disease; Estrogens; Gonadotropins, Pituitary; Gynecomastia; Hemochromatosis; Humans; Liver Cirrhosis; Male; Testicular Diseases; Thyroid Function Tests

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aged; Chronic Disease; Colitis; Enteritis; Female; Humans; Male; Middle Aged; Pituitary-Adrenal System

Topics: 17-Ketosteroids; Chronic Disease; Dehydroepiandrosterone; Female; Humans; Liver Diseases; Male

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Aged; Alcoholism; Back Pain; Chronic Disease; Female; Humans; Liver

Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Blood Chemical Analysis; Chronic Disease; Female; Humans; Male; Middle Aged; Prednisolone; Tuberculosis, Pulmonary

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acute Disease; Adrenocorticotropic Hormone; Adult; Chronic Disease; Female; Humans; Hypothalamo-Hypophyseal System; Male; Metyrapone; Middle Aged; Multiple Sclerosis; Neurologic Manifestations; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Stimulation, Chemical; Vasopressins

Topics: 17-Ketosteroids; Adult; Aged; Bronchitis; Chronic Disease; Gas Poisoning; Gastric Acidity Determination; Humans; Middle Aged; Peptic Ulcer; Smoking

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aged; Angiography; Chronic Disease; Coronary Disease; Electrocardiography; Female; Humans; Male; Metyrapone; Middle Aged; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adult; Antineoplastic Agents; Bacteria; Blood; Blood Proteins; Cervix Uteri; Chronic Disease; Dehydroepiandrosterone; Female; Humans; Leukocyte Count; Male; Menstruation; Mononuclear Phagocyte System; Oleandomycin; Oophoritis; Phagocytosis; Polysaccharides, Bacterial; Salpingitis; Serratia marcescens; Tetracycline; Urethra

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Age Factors; Chronic Disease; Endocrine Glands; Gonadotropins, Pituitary; Gonads; Humans; Middle Aged; Paranoid Disorders; Pituitary Gland; Puberty; Schizophrenia; Stimulation, Chemical; Thyroid Gland; Thyrotropin

Topics: 17-Ketosteroids; Adrenal Glands; Chronic Disease; Female; Humans; Male; Pulmonary Heart Disease; Tuberculosis, Pulmonary

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Asthma; Bronchitis; Child; Chronic Disease; Colitis, Ulcerative; Emphysema; Female; Humans; Lupus Erythematosus, Discoid; Male; Methylprednisolone; Nephrosis; Prednisone; Pregnanes; Triamcinolone

Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Berylliosis; Chronic Disease; Female; Humans; Middle Aged

Topics: 17-Ketosteroids; Adult; Atrophy; Chronic Disease; Fructose; Gonadotropins; Hepatitis; Humans; Libido; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Spermatozoa; Testicular Diseases

Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocorticotropic Hormone; Blood; Chronic Disease; Deficiency Diseases; Humans; Hydrocortisone; Hypoglycemia; Malnutrition; Pancreatic Diseases; Pituitary-Adrenal Function Tests

Topics: 17-Ketosteroids; Chronic Disease; Diagnosis, Differential; Humans; Male; Neoplasms; Prostatic Neoplasms; Prostatitis; Steroids

Topics: 17-Ketosteroids; Biological Assay; Chronic Disease; Dehydroepiandrosterone; Intraoperative Complications; Steroids; Urine